
CPHI South East Asia 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to CPHI South East Asia 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
CPHI South East Asia 2026
Event type: Pharmaceutical, API, biopharma, drug development, contract manufacturing, packaging, laboratory, supply chain, and healthcare manufacturing exhibition
Likely venue region: South East Asia
Audience profile: Regional and international pharma buyers, manufacturers, distributors, sourcing teams, regulatory professionals, suppliers, and solution providers
Estimated attendance: Typically a strong regional trade show with hundreds to thousands of targeted industry professionals, depending on final venue, co-located programs, and exhibitor participation
1️⃣ Who attends: Buyers / Attendees
CPHI South East Asia 2026 is a business-to-business pharmaceutical supply chain event, so the most valuable attendees are not general consumers. The real buyer audience is made up of commercial, technical, procurement, and R&D decision-makers across pharma and healthcare manufacturing. This is an excellent event for reaching professionals who influence sourcing, vendor selection, product development, compliance, and manufacturing partnerships.
Typical attendee groups include:
- Procurement managers and strategic sourcing teams from pharmaceutical companies
- Business development and partnership leaders from contract development and manufacturing organizations
- R&D directors, formulation scientists, and product development teams
- Quality assurance, quality control, and regulatory affairs professionals
- Manufacturing and operations leaders in pharma, biotech, and nutraceutical companies
- Packaging, logistics, and supply chain decision-makers
- Distributors, importers, exporters, and regional channel partners
- Laboratory and testing solution buyers
- Hospital, pharmacy, and healthcare supply chain teams where relevant
- Government, association, and trade development stakeholders
For attendee-list sales, the strongest commercial value is in people who can evaluate suppliers, approve purchases, manage product pipelines, or build distribution networks.
2️⃣ Where the show is happening + attendee geographic origin
CPHI South East Asia is positioned as a regional pharmaceutical industry meeting point for the ASEAN market. The location is usually within a major business hub in South East Asia, which makes it highly attractive for local, regional, and cross-border attendees.
Geographic origin of attendees:
- Local: Strong representation from the host country and nearby metro areas
- Regional: High participation from ASEAN markets such as Thailand, Malaysia, Singapore, Indonesia, Vietnam, Philippines, and surrounding countries
- International: Global suppliers, multinational pharma companies, and overseas service providers attending to access South East Asia demand
This event should be treated as a regional gateway show with international buyer relevance. If your client sells to pharma manufacturers, contract manufacturers, packaging firms, lab suppliers, or healthcare distributors, this audience is especially valuable.
3️⃣ Audience reach: Local / National / Global
Audience reach type: Regional with global buyer participation
The event is not simply local. It is a South East Asia platform with a broader international supply chain impact. While many attendees will come from the host country and ASEAN region, the exhibitor and buyer ecosystem typically includes multinational pharma players, export-oriented manufacturers, and foreign solution providers.
In practical terms, the reach is:
- Local for domestic pharma manufacturers, distributors, and healthcare buyers
- Regional for ASEAN-based sourcing and partnership development
- Global for companies targeting South East Asia as an expansion market
4️⃣ Sample buyer company names + websites
Below is a sample buyer list you can use as a starting point for attendee and account targeting. These are buyer-side or buyer-influencing companies that fit pharma, biotech, manufacturing, healthcare supply, distribution, packaging, or lab procurement. The purpose is to identify companies likely to attend, exhibit, source, or evaluate suppliers.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Pfizer | pfizer.com | Procurement Director / Supplier Relationship Manager / Regional Commercial Lead | Global pharma buyer with strong interest in sourcing, partnerships, manufacturing, and supply chain expansion. |
| 2 | Sanofi | sanofi.com | Category Manager / Manufacturing Operations Lead / Business Development Manager | Large pharma organization that regularly evaluates suppliers, contract manufacturing, and regional partners. |
| 3 | Novartis | novartis.com | Strategic Sourcing Manager / Regulatory Affairs Manager / External Manufacturing Lead | Strong buyer profile for pharma inputs, development services, and outsourcing partnerships. |
| 4 | GSK | gsk.com | Procurement Manager / Supply Chain Director / Product Development Manager | Relevant for sourcing, packaging, formulation support, and regional supply chain engagement. |
| 5 | Abbott | abbott.com | Regional Sales Director / Operations Manager / Product Manager | Healthcare and diagnostics buyer with interest in regional partnerships and product distribution. |
| 6 | Roche | roche.com | Market Access Manager / Procurement Lead / Laboratory Solutions Manager | Strong fit for diagnostics, lab technologies, and healthcare innovation suppliers. |
| 7 | Takeda | takeda.com | Supply Chain Manager / External Partner Manager / Quality Assurance Lead | Relevant for outsourcing, compliance, and regional manufacturing collaborations. |
| 8 | Sun Pharma | sunpharma.com | Procurement Head / Plant Operations Manager / Regulatory Affairs Lead | Large manufacturing footprint and strong interest in APIs, packaging, equipment, and compliance. |
| 9 | Dr. Reddy’s Laboratories | drreddys.com | Formulation Development Manager / Supply Chain Director / Procurement Manager | Buyer for APIs, formulations, contract services, and export-oriented pharma supply chains. |
| 10 | Cipla | cipla.com | Business Development Manager / Packaging Manager / Sourcing Lead | Good fit for pharmaceutical supply, product lifecycle, and regional partnerships. |
| 11 | Zuellig Pharma | zuelligpharma.com | Distribution Director / Category Manager / Healthcare Supply Chain Lead | Major regional healthcare distributor with strong relevance for pharma supply, warehousing, and channel growth. |
| 12 | DKSH | dksh.com | Commercial Director / Procurement Manager / Healthcare Services Lead | Regional distribution and market expansion company with pharma and healthcare focus. |
| 13 | McKesson | mckesson.com | Supply Chain Manager / Pharmacy Services Director / Vendor Management Lead | Large healthcare distribution and procurement organization with relevant buyer intent. |
| 14 | Becton, Dickinson and Company | bd.com | Product Manager / Procurement Lead / Manufacturing Operations Director | Medical device and diagnostics buyer with interest in manufacturing, packaging, and supply chain suppliers. |
| 15 | GE HealthCare | gehealthcare.com | Regional Sales Manager / Procurement Lead / Partnership Director | Relevant for healthcare technology, diagnostics, service networks, and regional expansion. |
| 16 | B. Braun | bbraun.com | Operations Manager / Sourcing Manager / Regulatory Affairs Manager | Strong buyer fit for medical products, sterilization, packaging, and manufacturing services. |
| 17 | Thermo Fisher Scientific | thermofisher.com | Lab Solutions Manager / Procurement Director / Channel Sales Manager | Excellent fit for laboratory equipment, testing, and scientific supply buyers. |
| 18 | Amgen | amgen.com | External Manufacturing Lead / Quality Manager / Strategic Sourcing Manager | Relevant for biopharma services, compliance, outsourcing, and partnership development. |
Top 5 buyer accounts to prioritize first: Pfizer, Sanofi, Novartis, Zuellig Pharma, Thermo Fisher Scientific. These names give a balanced mix of pharma manufacturing, regional distribution, and lab procurement value.
5️⃣ Job profiles, industries & event type
This event attracts a sophisticated B2B audience with strong buying authority. The best contacts are usually not junior attendees; they are people who manage sourcing, partnerships, operations, compliance, or product strategy.
Best job profiles to target:
- Procurement Director
- Strategic Sourcing Manager
- Supply Chain Director
- Business Development Manager
- Regional Commercial Manager
- Manufacturing Operations Manager
- Quality Assurance Manager
- Regulatory Affairs Manager
- Product Development Manager
- Formulation Scientist
- External Manufacturing Lead
- Category Manager
- Packaging Development Manager
- Laboratory Procurement Manager
- Distribution Director
- Healthcare Supply Chain Manager
Best industries to use from your industry list:
- Pharmaceuticals
- Biotechnology
- Medical Devices
- Hospital & Health Care
- Health, Wellness & Fitness
- Medical Practice
- Research
- Chemicals
- Packaging & Containers
- Logistics & Supply Chain
- Import & Export
- Information Services
- Market Research
- Management Consulting
- Wholesale
- Retail
- Professional Training & Coaching
Event type: Pharmaceutical manufacturing and sourcing exhibition with strong buyer-seller networking, supplier discovery, product development, and regional market expansion opportunities.
6️⃣ Estimated attendance / expected total footfall
CPHI events are typically high-value trade environments rather than mass-public expos. The exact attendance for the 2026 South East Asia edition will depend on venue, city, exhibitor count, and co-located programs, but the likely footfall should be viewed as a concentrated professional audience.
Estimated attendance range:
- Conservative estimate: 3,000 to 5,000 professionals
- Healthy trade-show estimate: 5,000 to 10,000 professionals
- Strong regional edition with major exhibitors: 10,000+ professionals
Even if total footfall is moderate compared with consumer expos, the buyer quality is usually much stronger. For attendee-list sales, this means the list may be smaller than a mass event, but the commercial value per contact is typically higher.
7️⃣ Key focus areas & buyer engagement
This event is highly relevant for companies selling into the pharmaceutical value chain. Engagement is strongest when the message is specific and commercial, not generic.
Key focus areas:
- API sourcing and ingredient supply
- Contract manufacturing and outsourced production
- Drug formulation and development
- Packaging, labeling, and serialization
- Quality, compliance, and regulatory support
- Laboratory equipment and testing services
- Cold chain, logistics, and distribution
- Biopharma and advanced therapeutic development
- Healthcare market access and regional expansion
- Supplier discovery and procurement networking
Buyer engagement strategy:
- Target decision-makers involved in vendor selection and supply chain optimization
- Prioritize companies with regional manufacturing or distribution operations
- Focus on attendees responsible for procurement, R&D, quality, and partnerships
- Tailor the pitch by product category: ingredients, packaging, equipment, testing, logistics, or consulting
- Segment contacts by company size, buying role, and regional coverage
The best engagement angle is to position the attendee list as a pharma buyer and supply-chain intelligence database, not as a general event contact list. That makes the offer more relevant to clients looking for qualified commercial opportunities.
8️⃣ Client product review requirement
To recommend the best buyers from this event with high accuracy, I need your client website first. The ideal buyer list depends heavily on what your client sells.
For example:
- If your client sells lab equipment, the best buyers are procurement heads, lab managers, and scientific sourcing teams.
- If your client sells packaging solutions, the best buyers are packaging development, operations, and manufacturing teams.
- If your client sells software or digital tools, the best buyers are R&D, regulatory, quality, and supply chain leaders.
- If your client sells services, the best buyers are business development, outsourcing, and partnership decision-makers.
- If your client sells ingredients or raw materials, the best buyers are formulation, procurement, and manufacturing leaders.
Please share the client website so I can review the product positioning and identify the best-fit buyer companies, job titles, and industry filters for this exact event.
9️⃣ Industry suggestions based on your industry list
For this event, the strongest industry selections are the ones most closely aligned with pharmaceutical manufacturing, healthcare supply, scientific services, and distribution. Below are the best industry choices to use when building a targeted attendee list.
Primary industries to prioritize:
- Pharmaceuticals
- Biotechnology
- Medical Devices
- Hospital & Health Care
- Research
- Chemicals
- Logistics & Supply Chain
- Import & Export
- Packaging & Containers
- Wholesale
Secondary industries to include when relevant:
- Health, Wellness & Fitness
- Medical Practice
- Information Services
- Market Research
- Management Consulting
- Professional Training & Coaching
- Manufacturing-related categories through company-level keyword targeting
Final recommendation
CPHI South East Asia 2026 is a strong event for B2B attendee-list sales because it attracts a buyer-rich pharmaceutical ecosystem with clear procurement and partnership intent. The best value comes from targeting company decision-makers in pharma, biotech, healthcare distribution, packaging, lab services, and supply chain functions.
This is not a broad consumer event. It is a specialized industry marketplace where the quality of the contact list matters more than raw volume. If your client sells into pharma manufacturing, scientific services, packaging, logistics, or healthcare supply, this show can deliver highly relevant buyer profiles.
Best overall buyer segments:
- Procurement and sourcing leaders
- Pharma manufacturing and operations managers
- R&D and formulation teams
- Quality and regulatory professionals
- Regional distributors and channel partners
- Lab and testing solution buyers
- Contract manufacturing and outsourcing decision-makers
Buyer fit quality rating for attendee-list sales: 8.5/10
Strong regional event, excellent industry alignment, high-value commercial audience, and clear demand for supplier discovery. The final buyer shortlist should be refined after reviewing your client website and product category.
Data sheet
| Event Name | CPHI South East Asia 2026 |
| Event Date | 8 July 2026 - 10 July 2026 |
| Event Status | Upcoming |
| Venue | Queen Sirikit National Convention Center (QSNCC) |
| City | Bangkok |
| State / Region | Bangkok |
| Country | Thailand |
| Organizer | CPHI / Informa Markets (brand and event ownership to be verified against the live 2026 event page) |
| Official Event Website | cphi.com/sea |
| Event Type | B2B pharmaceutical manufacturing, ingredients, outsourcing, packaging, laboratory, and supply chain exhibition and conference |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Packing & Packaging; Industrial Engineering; Logistics & Transportation |
| Audience Reach | Regional primary reach across South East Asia, with broader Asia-Pacific and international supplier participation likely |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Current-year attendance not publicly confirmed. Final attendee, buyer, and exhibitor counts should be validated using the official 2026 event pages, prospectus, or post-show report. |
| Main Purpose of Event | To connect pharmaceutical ingredient suppliers, finished-dose manufacturers, CDMOs/CMOs, packaging providers, equipment suppliers, laboratory and quality teams, regulatory professionals, and regional buying organizations for sourcing, partnerships, manufacturing, and market access. |
CPHI South East Asia 2026 is a specialized B2B pharmaceutical supply chain event serving ingredient sourcing, manufacturing, biopharma, outsourcing, packaging, quality, laboratory, and market-access functions. Based on the event brand positioning and regional scope, the show is designed to bring together pharma producers, contract manufacturers, distributors, technical teams, and commercial decision-makers operating across Thailand and the wider ASEAN market.
For exhibitors and sales teams, the event matters because it concentrates procurement, sourcing, operations, R&D, regulatory, and partnership stakeholders in one venue. It is particularly relevant for companies selling APIs, excipients, dosage-form technologies, packaging, cleanroom and plant equipment, laboratory services, quality solutions, CDMO services, and pharmaceutical supply-chain capabilities. The event is suitable for B2B attendee list building, provided participant verification is taken from official 2026 directories, sponsorship pages, agendas, or post-show materials.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Procurement and strategic sourcing teams | Pharmaceutical manufacturers, generic drug producers, branded pharma companies, nutraceutical and healthcare manufacturers | Supplier qualification, RFQs, cost benchmarking, API and excipient sourcing, packaging and equipment selection | High-value target group for ingredients, components, machinery, outsourced services, and supply contracts |
| CDMO / CMO business development leaders | Contract development and manufacturing organizations, formulation and fill-finish service providers | Partnership evaluation, manufacturing transfer, outsourcing decisions, commercial alliances | Important for outsourcing deals, capacity partnerships, and co-development conversations |
| R&D and formulation teams | Drug developers, formulation labs, innovation centers, technical product teams | Evaluation of new ingredients, delivery systems, stability, technical performance, development support | Key buyers for differentiated materials, technical services, and development tools |
| Quality assurance and quality control professionals | Manufacturing plants, analytical labs, compliance and validation teams | Approval influence for GMP systems, testing, validation, documentation, laboratory instrumentation | Critical technical gatekeepers for regulated product adoption |
| Regulatory affairs and compliance leaders | Pharma companies, importers, market authorization holders, compliance consultants | Influence over approved materials, documentation packages, market-entry compliance, supplier eligibility | Relevant for suppliers offering regulatory-ready ingredients, dossiers, testing, and compliance support |
| Manufacturing and operations leaders | Finished-dose plants, biologics facilities, packaging sites, sterile and non-sterile operations | Plant efficiency, equipment acquisition, process improvement, capacity expansion | Best-fit audience for plant systems, packaging lines, cleanroom solutions, and industrial automation |
| Supply chain and distribution teams | Regional pharma distributors, importers, wholesalers, cold-chain operators | Sourcing continuity, vendor diversification, logistics qualification, inventory and traceability decisions | Relevant for packaging, serialization, logistics, warehousing, and import/export service providers |
| Corporate business development and partnerships teams | Pharma groups, ingredient companies, technology licensors, service firms | Alliance building, licensing, channel partnerships, regional distribution deals | Useful for channel expansion and strategic partnership outreach |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Bangkok | Local pharma manufacturers, importers, distributors, regional offices, healthcare supply chain firms | High | Immediate access to Thailand-based pharma decision-makers and country management teams |
| Thailand | National manufacturers, hospitals-linked suppliers, packaging firms, regulatory and quality professionals | High | Domestic buyer pool is relevant for manufacturing supply, import substitution, and plant modernization |
| ASEAN markets | Buyers and technical teams from Singapore, Malaysia, Indonesia, Vietnam, Philippines, Cambodia, Laos, Myanmar, Brunei | Very High | Core regional reach for ingredient sourcing, outsourced manufacturing, and regulatory networking |
| Wider Asia-Pacific | India, China, Japan, South Korea, Taiwan, Australia, New Zealand | Medium to High | Relevant for API sourcing, formulation know-how, equipment supply, and regional market development |
| International supplier markets | Europe, North America, Middle East | Medium | More common among ingredient, packaging, technology, and CDMO suppliers than buyer-side attendees |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Regional | Primary classification | The event is positioned around South East Asia and is most relevant for ASEAN pharmaceutical sourcing, manufacturing, and distribution networks. |
| International | Secondary characteristic | The CPHI brand typically attracts cross-border supplier participation and international partnership interest, but the strongest buyer density is regional rather than fully global. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Current-year buyer organization names not publicly released | Attendee data status | Organizer has not publicly published a verified 2026 attendee or hosted buyer list in the reviewed materials. | cphi.com/sea | Procurement Director; Sourcing Manager; Business Development Director | Confirmed Government / Procurement Organization |
| Official 2026 exhibitor directory pending / verify when live | Data release status | Use the official exhibitor or partner directory to identify manufacturing companies that also buy ingredients, packaging, equipment, testing, and outsourcing services. | cphi.com/sea | Head of Procurement; Plant Director; QA Director | Confirmed Current-Year Participant |
| Official 2026 speaker organization list pending / verify when live | Data release status | Speaker organizations often reveal high-value pharma manufacturers, trade associations, technical experts, and regulatory stakeholders relevant for outreach. | cphi.com/sea | Regulatory Affairs Director; VP Manufacturing; R&D Director | Confirmed Speaker Organization |
| Official matchmaking / networking portal pending | Buyer discovery channel | If enabled for 2026, the networking tool can surface validated participating companies, functions, and meeting demand by category. | cphi.com/sea | Category Manager; Technical Purchasing Manager; Partnerships Director | Confirmed Current-Year Participant |
| Thailand-based pharmaceutical manufacturers | Regional buyer segment | Core buyer cluster for APIs, excipients, machinery, packaging, QA/QC systems, and CDMO services. | To be validated via official directory | Procurement Manager; Manufacturing Director; QA Manager | Prior-Year Participation Evidence |
| ASEAN generic and branded drug manufacturers | Regional buyer segment | Likely to attend for sourcing, outsourcing, packaging, compliance, and regional partnerships. | To be validated via official directory | Strategic Sourcing Manager; Regulatory Director; Operations Director | Prior-Year Participation Evidence |
| Regional pharmaceutical distributors and importers | Channel buyers | Important for market-entry, commercialization, sourcing continuity, and warehousing/logistics qualification. | To be validated via official directory | Supply Chain Director; Import Manager; Partnerships Director | Prior-Year Participation Evidence |
| Biopharma and specialty manufacturing organizations | Advanced manufacturing buyers | Potential buyers of high-spec ingredients, sterile manufacturing services, analytical support, and cold-chain solutions. | To be validated via official directory | Head of Technical Operations; Director Biologics; QC Director | Prior-Year Participation Evidence |
| CMOs / CDMOs expanding ASEAN customer base | Service buyers and partners | These firms can buy raw materials, equipment, packaging, and validation services while also acting as strategic partners. | To be validated via official directory | Business Development Director; Procurement Lead; Site Head | Prior-Year Participation Evidence |
| Laboratory and quality testing service organizations | Technical buying segment | Relevant buyers of lab equipment, consumables, software, validation tools, and analytical standards. | To be validated via official directory | Laboratory Manager; QC Manager; Validation Manager | Prior-Year Participation Evidence |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Director of Procurement | Procurement | Director | Owns sourcing strategy, approved vendors, and cost management. |
| 2 | Strategic Sourcing Manager | Procurement | Manager | Key contact for RFQs, supplier onboarding, and category sourcing. |
| 3 | Supply Chain Director | Supply Chain | Director | Influences supplier diversification, inventory resilience, and logistics qualification. |
| 4 | Business Development Director | Business Development | Director | Critical for CDMO, licensing, channel, and strategic partnership conversations. |
| 5 | Manufacturing Director | Operations | Director | Approves plant technologies, capacity expansion, and process systems. |
| 6 | Plant Manager / Site Head | Manufacturing | Manager / VP | Operational buyer for packaging lines, utilities, quality systems, and equipment. |
| 7 | R&D Director | Research & Development | Director | Evaluates technical differentiation and development compatibility. |
| 8 | Formulation Scientist / Technical Manager | R&D | Manager / Individual Contributor | Influences excipient, ingredient, and dosage-form technology selection. |
| 9 | QA Director / Head of Quality | Quality | Director | Gatekeeper for GMP, vendor qualification, audits, and compliance acceptance. |
| 10 | Regulatory Affairs Director | Regulatory Affairs | Director | Essential where documentation, regional approvals, and compliant supply are critical. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Pharmaceuticals | Core industry for finished-dose, branded, and generic drug manufacturers | API sourcing, packaging, CDMO partnerships, regulatory support |
| 2 | Biotechnology | Relevant to biologics, advanced therapy, and innovation teams | Process development, sterile manufacturing, analytical support |
| 3 | Medical Devices | Adjacent regulated manufacturing audience with packaging and quality overlap | Packaging, cleanroom, quality, sterilization, testing |
| 4 | Hospital & Health Care | Selective relevance for hospital procurement, compounding, and healthcare supply organizations | Specialty sourcing and compliance-led purchasing |
| 5 | Chemicals | Important for ingredient manufacturers and specialty input suppliers | Excipients, intermediates, processing aids |
| 6 | Packaging & Containers | Strong fit for primary and secondary pharmaceutical packaging stakeholders | Blister packs, bottles, closures, serialization, labels |
| 7 | Mechanical or Industrial Engineering | Useful for plant equipment, process systems, and automation vendors | Production lines, process optimization, facility upgrades |
| 8 | Industrial Automation | Relevant to smart manufacturing, process control, and plant productivity | Automation, MES, sensors, monitoring |
| 9 | Logistics & Supply Chain | Relevant for cold chain, warehousing, import/export, and pharma distribution | Regional supply continuity and compliant distribution |
| 10 | Import & Export | Useful for cross-border ingredient and finished-product channels | Market-entry and distributor sourcing |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Not publicly confirmed | Official 2026 event materials reviewed did not provide a final published count | Use post-show report or media release for final verification |
| Exhibitor count | Not publicly confirmed in reviewed materials | Pending | Official directory / sponsor pages | Validate once exhibitor directory is fully published |
| Buyer count | Not publicly confirmed | Pending | Organizer buyer program or matchmaking release | No verified hosted buyer count identified |
| Speaker count | Not publicly confirmed | Pending | Official agenda / conference page | Speaker organizations should be monitored for buyer intelligence |
| Sponsor count | Not publicly confirmed | Pending | Official sponsor page | Useful for partner ecosystem mapping but not a direct buyer count |
| Historical attendance | Historical / prior-year evidence should be checked in official post-show reports | Historical / prior-year evidence | Official prior-edition recap pages | Do not use historical counts as a confirmed 2026 attendance figure |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| API and excipient sourcing | Qualified supply, competitive pricing, documentation, technical fit | Direct meetings with procurement, R&D, and regulatory teams | Ingredients, intermediates, formulation support, dossier packages |
| Contract manufacturing and outsourcing | Capacity access, speed to market, technology transfer, regional expansion | Partnership and alliance discussions with BD and operations leaders | CDMO / CMO services, fill-finish, formulation, packaging |
| Pharma packaging | Compliance, shelf-life protection, branding, traceability | Packaging line sourcing and vendor qualification conversations | Primary and secondary packaging, labels, serialization, tamper evidence |
| Laboratory and quality systems | Testing accuracy, compliance, validation, data integrity | Technical demos for QA/QC and lab leadership | Analytical instruments, software, consumables, validation services |
| Manufacturing technology | Efficiency, scale-up, reliability, GMP readiness | Operations-led discussions around plant upgrades and line performance | Process equipment, automation, cleanroom systems, utility solutions |
| Regulatory and compliance readiness | Approved materials, auditability, market-entry support | Thought leadership and technical credibility with regulatory stakeholders | Documentation, audits, validation, quality consulting |
| Pharma supply chain resilience | Multi-source supply, logistics reliability, import/export efficiency | Supply continuity and regional network discussions | Cold chain, freight, warehousing, customs support, track-and-trace |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The event is tightly aligned with pharma manufacturing, sourcing, regulatory, and outsourcing buying functions. |
| Decision-maker availability | High | Director- and manager-level stakeholders are likely to attend, especially from procurement, quality, operations, and BD. |
| Data collection potential | Medium | High potential if official directories and networking tools are available; low confidence if relying only on public attendee disclosures. |
| Apollo targeting potential | Very High | Clear industry, job-function, and geography filters make this event highly usable for account-based outreach. |
| Geographic targeting potential | High | Thailand plus ASEAN is a practical and commercially coherent region for targeting. |
| Best outreach approach | High | Use account-led outreach to pharma manufacturers, CDMOs, packaging buyers, and QA/regulatory leaders tied to ASEAN expansion or compliant sourcing. |
| Overall lead quality | High | Strong event fit for specialized pharma B2B sales, especially when current-year participant verification is available. |
| Best use case | High | Ideal for lead generation, partnership prospecting, supplier outreach, regional buyer mapping, and event-based ABM. |
| Limitations / risks | Medium | Public current-year attendee names may be limited; avoid assuming attendance without official confirmation. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Pharmaceuticals; Biotechnology; Medical Devices; Chemicals; Packaging & Containers; Mechanical or Industrial Engineering; Industrial Automation; Logistics & Supply Chain; Import & Export; Hospital & Health Care | Build a regional pharma supply-chain account list |
| Departments | Procurement; Supply Chain; Operations; Manufacturing; Quality Assurance; Regulatory Affairs; Research & Development; Business Development | Focus on decision-makers and technical influencers |
| Seniority | Manager; Director; VP; CXO; Head | Prioritize budget owners and approvers |
| Job titles | Procurement Director; Strategic Sourcing Manager; Supply Chain Director; Manufacturing Director; Plant Manager; QA Director; Regulatory Affairs Director; R&D Director; Formulation Manager; Business Development Director; Partnerships Director; Technical Purchasing Manager | Mirror the most relevant event attendee functions |
| Geography | Thailand; Singapore; Malaysia; Indonesia; Vietnam; Philippines; Cambodia; Laos; Myanmar; Brunei; optionally India and China for supplier-partner targeting | Align with regional reach and likely buyer origins |
| Employee size | 51-200; 201-500; 501-1000; 1001-5000; 5001+ | Capture both mid-market and enterprise pharma operators |
| Keywords | API, excipient, formulation, GMP, CDMO, CMO, fill-finish, sterile, packaging, quality control, regulatory affairs, validation, cold chain, pharma manufacturing | Refine to event-relevant subsegments |
| Technologies, if relevant | MES, LIMS, ERP, serialization, cleanroom systems, process automation | Useful for plant-tech, quality-tech, and digital manufacturing offers |
| Revenue range, if relevant | Mid-market to enterprise; prioritize firms with manufacturing footprint or regional distribution reach | Improves enterprise deal focus |
| Company type | Manufacturers, CDMOs, importers, distributors, packaging firms, laboratory service organizations | Maps to the event’s commercial ecosystem |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| CPHI South East Asia official event site | Official event website | Event branding, date references, event focus, regional positioning, and official updates | High |
| Queen Sirikit National Convention Center (QSNCC) | Official venue website | Venue identity and Bangkok location details | High |
| CPHI global brand site | Official organizer / brand ecosystem | Brand ownership context, event family, and pharmaceutical event positioning | High |
| Official 2026 exhibitor directory, agenda, sponsor pages, and matchmaking portal | Official event materials | Needed to verify current-year participant organizations, speaker companies, sponsor lists, and any attendance metrics | High when live |
| Verification note | Research limitation | No public 2026 attendee list or confirmed buyer-company list was identified in the reviewed materials. Attendance, exhibitor counts, and speaker counts should not be treated as confirmed until published by the organizer. | Critical note |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to CPHI South East Asia 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.